PharmAla Biotech Holdings, Inc.'s total assets for Q1 2025 were C$2.63M, a decrease of -8.47% from the previous quarter. TSE:MDMA total liabilities were C$724.83K for the fiscal quarter, a -17.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.